5-methoxy-N-methyl,N-isopropyl tryptamine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 2763156 |
| CHEMBL ID | 172139 |
| SCHEMBL ID | 2782171 |
| MeSH ID | M0507619 |
| Synonym |
|---|
| I-7975 |
| n-isopropyl-n-methyl-5-methoxytryptamine, free base |
| n-[2-(5-methoxy-1h-indol-3-yl)ethyl]-n-methyl-propan-2-amine |
| CHEMBL172139 |
| n-[2-(5-methoxy-1h-indol-3-yl)ethyl]-n-methylpropan-2-amine |
| A845542 |
| n-[2-(5-methoxy-1h-indol-3-yl)ethyl]-n-methyl-2-propanamine |
| 5-methoxy-n,n-methylisopropyltryptamine |
| 96096-55-8 |
| 5-meo-mipt |
| unii-l0p1807euy |
| 5-methoxy-n-methyl-n-isopropyltryptamine |
| moxy |
| 5-methoxy-n-methyl,n-isopropyl tryptamine |
| l0p1807euy , |
| AKOS015918822 |
| 1h-indole-3-ethanamine,5-methoxy-n-methyl-n-(1-methylethyl)- |
| SCHEMBL2782171 |
| HEDOODBJFVUQMS-UHFFFAOYSA-N |
| 5-methoxy-n-methyl-n-(1-methylethyl)-1h-indole-3-ethanamine |
| n-(2-(5-methoxy-1h-indol-3-yl)ethyl)-n-methylpropan-2-amine |
| 5-methoxy-n-isopropyl-n-methyltryptamine |
| 1h-indole-3-ethanamine, 5-methoxy-n-methyl-n-(1-methylethyl)- |
| DTXSID90242114 |
| Q4412834 |
| methyl5-methylthio-1,2,4-thiadiazol-3-ylcarbamate |
| 5-methoxy-n-methyl-n-isopropyl tryptamine |
| WDA09655 |
| [2-(5-methoxy-1h-indol-3-yl)ethyl](methyl)(propan-2-yl)amine |
| PD020019 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID179647 | Hallucinogenic activity in rats and the effective dose required for the elicitation of the complete psychotomimetic spectrum was determined. | 1985 | Journal of medicinal chemistry, Jul, Volume: 28, Issue:7 | Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents. |
| AID174631 | Duration of time in hours, after ingestion at which central effects begin to decline was determined. | 1985 | Journal of medicinal chemistry, Jul, Volume: 28, Issue:7 | Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents. |
| AID188136 | Onset time in minutes, between ingestion and the first noticeable symptoms was determined | 1985 | Journal of medicinal chemistry, Jul, Volume: 28, Issue:7 | Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.94) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 2 (40.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 3 (60.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||